Ratings by LifeSci Capital
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 6/16/2026 | N/A | Veradermics | MANE | New Coverage | Outperform (N/A) |
135.00 (N/A) |
96.27 (111.32) |
15.63% | Details |
| 4/24/2026 | N/A | Inhibrx Biosciences | INBX | New Coverage | Outperform (N/A) |
200.00 (N/A) |
119.93 (87.39) |
-27.13% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 41 more... | |||||||||
